Sort   by:  
 Page size 
UnknownVarying Doses of Epicutaneous Immunotherapy With Viaskin Milk vs Placebo in Children With Cow's Milk Allergy: A Randomized Clinical Trial.
Not available
S-EPMC10897821 | biostudies-literature
TranscriptomicsTranscription profiling of human mononuclear cells after treatment with suppressor carbohydrates produced by CD8+ gd T cells in response to Mycobacterium tuberculosis
Mycobacterium tuberculosis (M.tb) infects 8 million and kills 2.2 million people each year worldwide. M.tb modulates the immune response of the infected individual. Empirically, suppressor carbohydrates (SC) produced by CD8+ gd T cells in response to M.tb were found to induce a T helper 2 response r...
ORGANISM(S): Homo sapiens 
2007-10-06 | E-MARS-7 | biostudies-arrayexpress
UnknownEffect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical Trial.
Not available
S-EPMC6439674 | biostudies-literature
UnknownEfficacy and safety of peanut epicutaneous immunotherapy in patients with atopic comorbidities.
Not available
S-EPMC10509968 | biostudies-literature
UnknownRisk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
Not available
S-EPMC3535539 | biostudies-literature
UnknownGenome-Wide Association Study of Late-Onset Myasthenia Gravis: Confirmation of TNFRSF11A and Identification of ZBTB10 and Three Distinct HLA Associations.
Not available
S-EPMC4749491 | biostudies-literature
UnknownEffect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity: A Randomized Clinical Trial.
Not available
S-EPMC5820709 | biostudies-literature
UnknownVolumetric laser endomicroscopy and its application to Barrett's esophagus: results from a 1,000 patient registry.
Not available
S-EPMC6853704 | biostudies-literature
UnknownProtein production and purification.
Not available
S-EPMC3178102 | biostudies-literature
UnknownMinimal manifestation status and prednisone withdrawal in the MGTX trial.
Not available
S-EPMC7455358 | biostudies-literature
Sort   by:  
 Page size